AllPennyStocks.com Earnings Estimates Moving Higher for Oceaneering International (OII): Time to Buy?
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Earnings Estimates Moving Higher for Oceaneering International (OII): Time to Buy?

Investors might want to bet on Oceaneering International (OII), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.

Analysts' growing optimism on the earnings prospects of this oilfield services company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- has this insight at its core.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For Oceaneering International, strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate Revisions

The company is expected to earn $0.58 per share for the current quarter, which represents a year-over-year change of +5.5%.

Over the last 30 days, one estimate has moved higher for Oceaneering International compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 9.43%.

Current-Year Estimate Revisions

For the full year, the company is expected to earn $2.10 per share, representing a year-over-year change of +8.8%.

In terms of estimate revisions, the trend for the current year also appears quite encouraging for Oceaneering International. Over the past month, one estimate has moved higher compared to no negative revisions, helping the consensus estimate increase 11.11%.

Favorable Zacks Rank

Thanks to promising estimate revisions, Oceaneering International currently carries a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom Line

Investors have been betting on Oceaneering International because of its solid estimate revisions, as evident from the stock's 23.5% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Oceaneering International, Inc. (OII): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Other Penny Stock Movers

Sub-Dollar Cancer Diagnostics Play Erupts on Q2 Revenue
Gold's New Bottleneck Isn't Capital; It's Equipment
Canadian Defense Tech Firm Jumps 92% as Government Revenue Boosts Margins
Most Popular
{{ index + 1 }}


Back to Top